Delivery Order SPE2DB22D2206-SPE2DB25FFR90

Award Date 2/18/25
Potential Completion Date 3/11/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of TESTOPEL 75 MG PELLETS 100S. The $4,115.58 Firm Fixed Price Delivery Order contract has an ultimate completion date of March 19, 2025. The award is not associated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $7,956.18 firm fixed price delivery order is for the supply of 100 units of the medication TESTOPEL 75 MG PELLETS. This contract award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TESTOPEL 75 MG PELLETS 100S. The contract has a firm fixed price of $11,934.27 and runs through September 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical for delivering a wide range of pharmaceutical and medical...
This federal contract award, valued at $3,978.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a period of performance through April 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FS02F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,978.08 firm fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product. The contract has an ultimate completion date of February 23, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This federal contract award, valued at $12,346.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB22D3004|SPE2DB25FNF36, is a Delivery Order valued at $3,978.09 with a Firm Fixed Price pricing type. The contract is for the provision of TESTOPEL 75 MG PELLETS 100S, a medical product, with a period of performance running through November 6, 2024. This award is not designated as a...
This federal contract award, valued at $2,132.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Testosterone 1% (25mg/2.5g) pharmaceutical products. It is a firm fixed-price delivery order contract with a completion date of February 10, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is a Delivery Order for $3,732.57 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "TESTOSTERONE 10 MG GEL PUMP 60GM" to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 3, 2024 and is a Firm Fixed Price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,203.21 Firm Fixed Price Delivery Order contract is for the supply of 4563079951 - TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM, with a performance period through December 13, 2023. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFR90
    Delivery Order

This federal contract award, valued at $4,115.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a medical product, and has an ultimate completion date of March 11, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/20/25, 2:30 PM